Alcon stock slips as revenue rises 8.0% in Q2
Published on 08/29/2026 at 06:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Alcon Inc. (CH0432492467) stock slips after the company reported second-quarter earnings of $0.84 a share on $2.4 billion in revenue, with revenue up 8.0% year over year and the shares last trading at $58.46 in Switzerland. The latest quarter was reported on August 10, 2026, and the stock was quoted lower again in recent trading.
Quarterly numbers
The second-quarter revenue figure of $2.4 billion and the $0.84 per-share result both point to a business still growing, even if the market has kept the valuation tight. The stock traded at $58.46 in the latest quoted session, while the market capitalization stood at CHF 28.26 billion and the 52-week range ran from $61.83 to $87.64 in one recent market snapshot.
The comparison that matters is the quarter-over-quarter backdrop: revenue was 8.0% higher than a year earlier, while the latest market view showed 368,288 shares changing hands and a consensus rating of Moderate Buy. That mix leaves investors focused on whether the current pace can narrow the gap to the stock's prior trading band.
Consensus view
Analyst estimates in recent market coverage put 2026 earnings per share at CHF 2.83, which gives the latest quarter a concrete benchmark for the rest of the year. The same coverage also placed the average target at $84.96, well above the last quoted U.S.-dollar level in the market snapshot.
For a company that sells eye-care equipment and vision-care products, the earnings path matters more than a single quarter. The result set suggests a business with steady top-line growth, but one still priced as if execution needs to keep improving.
Vision care products
Alcon's product mix spans surgical equipment and vision care, and that balance helps explain why investors watch both recurring demand and procedure volumes. Recent market coverage also noted a trailing 12-month EPS of $1.31, which sits below the 2026 consensus figure cited above.
Shares and valuation
Alcon stock last changed hands at $58.46 CHF in the latest quoted session, with a market capitalization of CHF 28.26 billion and a 52-week range of $61.83 to $87.64. The shares remain well below that range's upper end, even after the latest quarter showed 8.0% revenue growth and $0.84 in quarterly EPS.
Fact box
Company: Alcon Inc.
ISIN: CH0432492467
Ticker: ALC.SW
Exchange: SIX Swiss Exchange
Price (as of August 28, 2026, 12:28 p.m. CEST): CHF 58.46
Market cap: CHF 28.26 billion
Sector / Industry: Health Care / Medical Instruments & Supplies
Index membership: SMI
